2013 Q4 Form 10-K Financial Statement

#000119312515076564 Filed on March 04, 2015

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2013 Q2
Revenue $302.2M $301.3M $316.0M
YoY Change -13.71% -17.29% -14.66%
Cost Of Revenue $178.4M $175.2M $176.1M
YoY Change -9.81% -15.33% -13.09%
Gross Profit $123.8M $126.1M $138.2M
YoY Change -18.77% -19.89% -15.42%
Gross Profit Margin 40.97% 41.85% 43.73%
Selling, General & Admin $119.6M $119.8M $122.3M
YoY Change -10.81% -9.38% -10.92%
% of Gross Profit 96.61% 95.0% 88.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.700M $9.000M $9.600M
YoY Change -13.86% -9.09% -3.03%
% of Gross Profit 7.03% 7.14% 6.95%
Operating Expenses $124.4M $128.8M $131.6M
YoY Change -13.55% -9.3% -10.48%
Operating Profit -$600.0K -$154.2M $3.793M
YoY Change -107.06% -1104.08% -75.3%
Interest Expense -$1.400M $672.0K $730.0K
YoY Change -74.07% -66.09% -63.54%
% of Operating Profit 19.25%
Other Income/Expense, Net -$1.000M $6.253M $111.0K
YoY Change -127.78% -493.02% -106.51%
Pretax Income -$14.30M -$148.0M $3.300M
YoY Change -90.8% -1174.68% -75.83%
Income Tax -$5.300M -$56.93M $1.300M
% Of Pretax Income 39.39%
Net Earnings -$9.600M -$91.10M $1.800M
YoY Change -91.01% -1020.2% -77.22%
Net Earnings / Revenue -3.18% -30.24% 0.57%
Basic Earnings Per Share -$0.30 -$2.89 $0.06
Diluted Earnings Per Share -$0.30 -$2.89 $0.06
COMMON SHARES
Basic Shares Outstanding 32.46M shares 31.51M shares 31.16M shares
Diluted Shares Outstanding 31.51M shares 31.49M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.30M $43.60M $30.10M
YoY Change 19.31% 11.51% -19.09%
Cash & Equivalents $17.30M $43.63M $30.12M
Short-Term Investments
Other Short-Term Assets $10.79M $9.819M $27.00M
YoY Change -5.73% -52.42% 8.87%
Inventory
Prepaid Expenses $10.67M $11.46M
Receivables $111.1M $111.1M $124.8M
Other Receivables $5.700M $0.00 $0.00
Total Short-Term Assets $205.3M $234.4M $181.8M
YoY Change -0.25% 0.24% -23.06%
LONG-TERM ASSETS
Property, Plant & Equipment $159.0M $160.1M $156.9M
YoY Change 1.48% 6.05% 7.31%
Goodwill $208.9M $208.1M
YoY Change -0.33% -43.37%
Intangibles $36.70M $42.33M
YoY Change -21.91% -18.53%
Long-Term Investments $23.20M
YoY Change
Other Assets $26.28M $26.50M $109.2M
YoY Change 40.93% 56.23% 362.59%
Total Long-Term Assets $521.1M $520.2M $518.5M
YoY Change -0.7% -18.96% -16.64%
TOTAL ASSETS
Total Short-Term Assets $205.3M $234.4M $181.8M
Total Long-Term Assets $521.1M $520.2M $518.5M
Total Assets $726.4M $754.6M $700.3M
YoY Change -0.57% -13.83% -18.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.14M $24.36M $21.70M
YoY Change -30.97% 12.32% -11.16%
Accrued Expenses $57.57M $54.34M $130.4M
YoY Change 4.95% -15.7% 109.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $13.90M $34.90M $35.80M
YoY Change -61.18% -35.74% -41.02%
Total Short-Term Liabilities $312.4M $332.5M $191.0M
YoY Change 52.56% 43.65% -22.04%
LONG-TERM LIABILITIES
Long-Term Debt $33.00M $36.00M $39.00M
YoY Change -50.67% -46.95% -42.39%
Other Long-Term Liabilities $8.511M $8.297M $5.200M
YoY Change 82.21% 87.25% 21.67%
Total Long-Term Liabilities $41.51M $44.30M $39.00M
YoY Change -42.0% -38.72% -45.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $312.4M $332.5M $191.0M
Total Long-Term Liabilities $41.51M $44.30M $39.00M
Total Liabilities $353.9M $376.8M $236.7M
YoY Change 28.07% 24.04% -25.33%
SHAREHOLDERS EQUITY
Retained Earnings -$77.56M -$67.93M
YoY Change -516.61% -154.16%
Common Stock $467.9M $463.0M
YoY Change 3.79% 3.75%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.18M $18.08M
YoY Change 6.19% 6.14%
Treasury Stock Shares 875.0K shares 868.9K shares
Shareholders Equity $372.2M $377.0M $463.6M
YoY Change
Total Liabilities & Shareholders Equity $726.4M $754.6M $700.3M
YoY Change -0.57% -13.83% -18.41%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2013 Q2
OPERATING ACTIVITIES
Net Income -$9.600M -$91.10M $1.800M
YoY Change -91.01% -1020.2% -77.22%
Depreciation, Depletion And Amortization $8.700M $9.000M $9.600M
YoY Change -13.86% -9.09% -3.03%
Cash From Operating Activities $8.400M $27.90M $33.60M
YoY Change -46.15% 27.98% 58.49%
INVESTING ACTIVITIES
Capital Expenditures -$12.70M -$9.400M -$9.500M
YoY Change -21.12% -21.67% -5.0%
Acquisitions
YoY Change
Other Investing Activities $1.800M -$1.900M $2.200M
YoY Change -150.0% 375.0% -127.85%
Cash From Investing Activities -$11.00M -$11.30M -$7.400M
YoY Change -44.44% -8.13% -58.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -23.70M -3.100M -3.100M
YoY Change 15.61% -58.67% -58.11%
NET CHANGE
Cash From Operating Activities 8.400M 27.90M 33.60M
Cash From Investing Activities -11.00M -11.30M -7.400M
Cash From Financing Activities -23.70M -3.100M -3.100M
Net Change In Cash -26.30M 13.50M 23.10M
YoY Change 6.48% 575.0% -677.5%
FREE CASH FLOW
Cash From Operating Activities $8.400M $27.90M $33.60M
Capital Expenditures -$12.70M -$9.400M -$9.500M
Free Cash Flow $21.10M $37.30M $43.10M
YoY Change -33.44% 10.36% 38.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
60000
CY2014 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
-1684000
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32823000 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31247000 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29896000 shares
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12776000
CY2014 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
13089000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2013 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-97775000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-96178000
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
520148000
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3913000
CY2012Q4 amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
9324000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
156000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7217000
CY2012 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
-3045000
CY2012 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
-1346000
CY2012 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
-323000
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
454233000
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3181000
CY2013Q4 amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
8581000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
261000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6519000
CY2013 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
-2152000
CY2013 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
-1060000
CY2013 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
145000
CY2013 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
-163000
CY2013 amed Increase Decrease In Assets Of Equity Method Investment
IncreaseDecreaseInAssetsOfEquityMethodInvestment
-709000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
564000
CY2014 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
-579000
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2014Q4 amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
7062000
CY2014 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
350000
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2433000
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5597000
CY2012 amed Increase Decrease In Assets Of Equity Method Investment
IncreaseDecreaseInAssetsOfEquityMethodInvestment
-839000
CY2012 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
15931000
CY2012 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
501000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3168000
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3495000
CY2014 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3226000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65534000
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6104000
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
CY2014 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
-1549000
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28347000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
37383000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40059000
CY2014 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12499000
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1627000
CY2013 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
5146000
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16369000
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16461000
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21728000
CY2014 us-gaap Pension Expense
PensionExpense
6216000
CY2013 us-gaap Pension Expense
PensionExpense
7998000
CY2012 us-gaap Pension Expense
PensionExpense
10013000
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4592000
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2742000
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1471000
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
797000
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
699000
CY2012 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1442000
CY2014 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2025000
CY2013 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1650000
CY2012 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1575000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5290000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-41578000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
42840000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6269000
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
927000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-10622000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9876000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8072000
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-19994000
CY2013 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
3839000
CY2012 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-181000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
102263000
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
69494000
CY2014 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
11000
CY2013 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
128000
CY2012 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
312000
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1809000
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
631000
CY2014 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
132000
CY2013 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
111000
CY2012 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
175000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12008000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41736000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48262000
CY2013 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
10067000
CY2012 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46458000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-59993000
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
261000
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
156000
CY2014 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
6407000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14300000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
564000
CY2014 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2433000
CY2014 amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
0
CY2014 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
226800000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
70563000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9271000
CY2014 us-gaap Notes Issued1
NotesIssued1
0
CY2012 us-gaap Notes Issued1
NotesIssued1
2214000
CY2012 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-31161000
CY2013Q4 amed Equipment And Furniture
EquipmentAndFurniture
106600000
CY2013Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
153300000
CY2013 amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
163000
CY2013 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3181000
CY2012 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3913000
CY2012 us-gaap Advertising Expense
AdvertisingExpense
4400000
CY2014 amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
488000
CY2013 amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
121000
CY2012 amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
573000
CY2014 amed Increase Decrease In Us Department Of Justice Settlement Accrual
IncreaseDecreaseInUsDepartmentOfJusticeSettlementAccrual
-150000000
CY2012 amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
323000
CY2014 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
241800000
CY2013 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
25500000
CY2012 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
CY2013 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
25500000
CY2012 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-53047000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-42960000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2758000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-33459000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48004000
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
68250000
CY2012 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
60000000
CY2014 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1780000
CY2012 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2265000
CY2014 us-gaap Interest Paid
InterestPaid
7602000
CY2012 us-gaap Interest Paid
InterestPaid
7779000
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1766000
CY2012 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2945000
CY2013 us-gaap Notes Issued1
NotesIssued1
0
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2013 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3385000
CY2013 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
576000
CY2013 us-gaap Interest Paid
InterestPaid
3990000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14545000
CY2014 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
2967000
CY2013 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1752000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
22561000
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-57095000
CY2014 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
57000
CY2012 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
CY2012 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
104441000
CY2013 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
55807000
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
13904000
CY2013 amed Increase Decrease In Us Department Of Justice Settlement Accrual
IncreaseDecreaseInUsDepartmentOfJusticeSettlementAccrual
150000000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1694000
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1596000
CY2014 amed Noncash Or Part Noncash Sale Acquisition Of Noncontrolling Interests
NoncashOrPartNoncashSaleAcquisitionOfNoncontrollingInterests
-1549000
CY2013 amed Noncash Or Part Noncash Sale Acquisition Of Noncontrolling Interests
NoncashOrPartNoncashSaleAcquisitionOfNoncontrollingInterests
145000
CY2012 amed Noncash Or Part Noncash Sale Acquisition Of Noncontrolling Interests
NoncashOrPartNoncashSaleAcquisitionOfNoncontrollingInterests
15931000
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our accounting and reporting policies conform with U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">G</font><font style="font-family:Times New Roman;font-size:10pt;">enerally Accepted Accounting Principles (&#8220;U.S. G</font><font style="font-family:Times New Roman;font-size:10pt;">AAP</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221;)</font><font style="font-family:Times New Roman;font-size:10pt;">. In preparing the consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. </font></p><p style='margin-top:9pt; margin-bottom:0pt'>&#160;</p>
CY2014 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Reclassifications and Comparability </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain </font><font style="font-family:Times New Roman;font-size:10pt;">reclassifications have been made to prior periods' financial statements in order to conform to the current period'</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;"> presentation</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">Our exit activity during the last three years may affect the comparability of our operating results</font><font style="font-family:Times New Roman;font-size:10pt;">. I</font><font style="font-family:Times New Roman;font-size:10pt;">n accordance</font><font style="font-family:Times New Roman;font-size:10pt;"> with applicable accounting guidance</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> the results of operations for the care centers</font><font style="font-family:Times New Roman;font-size:10pt;"> closed, sold or classified as held for sale</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">during 2012 and 2013 </font><font style="font-family:Times New Roman;font-size:10pt;">are presented in</font><font style="font-family:Times New Roman;font-size:10pt;"> discontinued operations in our </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements. See Note 3</font><font style="font-family:Times New Roman;font-size:10pt;"> &#8211; Discontinued Operations and Assets Held for Sale </font><font style="font-family:Times New Roman;font-size:10pt;">for additional information regarding our discontinued operations.</font></p><p style='margin-top:9pt; margin-bottom:0pt'>&#160;</p>
CY2014Q4 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.50 pure
CY2012 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.82 pure
CY2014Q4 us-gaap Cost Method Investments
CostMethodInvestments
5000000
CY2014Q4 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
34 States
CY2013Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
11900000
CY2014Q4 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.20 pure
CY2014Q4 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.50 pure
CY2014Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
18800000
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
5000000
CY2014 amed Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
60
CY2014 amed Episodes In Progress That Begin During Reporting Period
EpisodesInProgressThatBeginDuringReportingPeriod
60
CY2014 amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 Number_of_Visits
CY2014 amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 Number_of_Visits
CY2014 amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 Number_of_Visits
CY2014 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
CY2013 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
CY2012 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
CY2014 amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.10 pure
CY2014 amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 Number_of_Visits
CY2014 amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99 pure
CY2014 amed Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
365
CY2014 amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.6 pure
CY2014 amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.5 pure
CY2014 amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120
CY2014Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
19800000
CY2014Q4 amed Legal And Other Settlements
LegalAndOtherSettlements
5200000
CY2014Q4 amed Lease Liability
LeaseLiability
800000
CY2014Q4 amed Charity Care
CharityCare
700000
CY2014Q4 amed Equipment And Furniture
EquipmentAndFurniture
97200000
CY2014 amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1 pure
CY2014 amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60
CY2014 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
5100000
CY2012 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
9900000
CY2014 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.69 pure
CY2013 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.67 pure
CY2013 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
9000000
CY2014Q4 us-gaap Land
Land
3200000
CY2014Q4 amed Building And Leasehold Improvements
BuildingAndLeaseholdImprovements
25300000
CY2014Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
158200000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
283900000
CY2013Q4 us-gaap Land
Land
3200000
CY2013Q4 amed Building And Leasehold Improvements
BuildingAndLeaseholdImprovements
25900000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
289000000
CY2014 us-gaap Depreciation
Depreciation
28000000
CY2013 us-gaap Depreciation
Depreciation
35200000
CY2012 us-gaap Depreciation
Depreciation
36300000
CY2014Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
2800000
CY2013Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
2200000
CY2014Q3 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
500000
CY2014 amed Unamortized Debt Issuance Cost Amortizatin Period
UnamortizedDebtIssuanceCostAmortizatinPeriod
P3Y9M18D
CY2014Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
116400000
CY2014 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2000000
CY2013 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2500000
CY2012 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1300000
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
106000 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
688000 shares
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
638000 shares
CY2014 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000 shares
CY2014 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
521000 shares
CY2013 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
CY2012 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2012 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
21000000
CY2013 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
-400000
CY2013 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-1300000
CY2012 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-157900000
CY2014 us-gaap Advertising Expense
AdvertisingExpense
4700000
CY2013 us-gaap Advertising Expense
AdvertisingExpense
3900000
CY2014 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
-300000
CY2014 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-300000
CY2014 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-100000
CY2013 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
31200000
CY2013 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-5300000
CY2013 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-2200000
CY2012 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
47200000
CY2012 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-5500000
CY2012 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-2200000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
37000000
CY2011Q4 us-gaap Goodwill
Goodwill
334700000
CY2012Q4 us-gaap Goodwill
Goodwill
209600000
CY2012 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
32800000
CY2013 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1000000
CY2014 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
-3300000
CY2014 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
-3100000
CY2013Q4 amed Lease Liability
LeaseLiability
1800000
CY2013Q4 amed Charity Care
CharityCare
600000
CY2013Q4 amed Estimated Medicare Cap Liability
EstimatedMedicareCapLiability
4000000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16300000
CY2013Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
1200000
CY2013 amed Other Intangibles Write Offs
OtherIntangiblesWriteOffs
-1100000
CY2012 amed Other Intangible Assets Additions
OtherIntangibleAssetsAdditions
4000000
CY2012 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
-4200000
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
-2800000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
47000000
CY2013 amed Other Intangible Assets Additions
OtherIntangibleAssetsAdditions
600000
CY2013 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
-8200000
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
-1600000
CY2014 amed Other Intangible Assets Additions
OtherIntangibleAssetsAdditions
0
CY2014 amed Other Intangibles Write Offs
OtherIntangiblesWriteOffs
-200000
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
-200000
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50000000
CY2014Q4 amed Payroll Tax Escrow
PayrollTaxEscrow
1000000
CY2013Q4 amed Payroll Tax Escrow
PayrollTaxEscrow
1200000
CY2013Q4 amed Medicare Withholds
MedicareWithholds
900000
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5700000
CY2013Q4 us-gaap Due From Joint Ventures Current
DueFromJointVenturesCurrent
1500000
CY2013Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1500000
CY2014Q4 amed Medicare Withholds
MedicareWithholds
100000
CY2014Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
15000000
CY2014Q4 us-gaap Due From Joint Ventures Current
DueFromJointVenturesCurrent
1400000
CY2014Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
2200000
CY2014Q4 amed Workers Compensation Deposits
WorkersCompensationDeposits
300000
CY2013Q4 amed Workers Compensation Deposits
WorkersCompensationDeposits
200000
CY2014Q4 amed Health Insurance Deposits
HealthInsuranceDeposits
1200000
CY2013Q4 amed Health Insurance Deposits
HealthInsuranceDeposits
1200000
CY2013Q4 amed Other Miscellaneous Deposits
OtherMiscellaneousDeposits
900000
CY2014Q4 amed Other Miscellaneous Deposits
OtherMiscellaneousDeposits
700000
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2800000
CY2013Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2200000
CY2013Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
16900000
CY2014Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
23800000
CY2014Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
4400000
CY2013Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
4900000
CY2014Q4 amed Estimated Medicare Cap Liability
EstimatedMedicareCapLiability
2800000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15800000
CY2013Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
12200000
CY2013Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
16500000
CY2013Q4 amed Legal And Other Settlements
LegalAndOtherSettlements
6200000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-15000000
CY2014Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
11200000
CY2014 amed Estimated Insurance Total
EstimatedInsuranceTotal
35900000
CY2013Q4 amed Deferred Compensation Plan Liability
DeferredCompensationPlanLiability
3400000
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
12000000
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
12000000
CY2013Q4 amed Uncertain Tax Benefits In Long Term Obligations
UncertainTaxBenefitsInLongTermObligations
3900000
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
46900000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
116400000
CY2014Q4 amed Total Leverage Ratio
TotalLeverageRatio
1.5 pure
CY2014Q4 amed Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
2.3 pure
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
104400000
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33000000
CY2012Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
225000000
CY2014Q4 amed Senior Secured Leverage Ratio
SeniorSecuredLeverageRatio
0.7 pure
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
24000000
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0
CY2014Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
70000000
CY2014Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
118000000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-13900000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-1100000
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.027 pure
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1600000
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1700000
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-13900000
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-43200000
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-25700000
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-5500000
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11200000
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1400000
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
9800000
CY2012 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
100000
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2014 amed Deferred Income Taxes For Continuing Operations
DeferredIncomeTaxesForContinuingOperations
22700000
CY2013 amed Deferred Income Taxes For Continuing Operations
DeferredIncomeTaxesForContinuingOperations
-57100000
CY2012 amed Deferred Income Taxes For Continuing Operations
DeferredIncomeTaxesForContinuingOperations
-31200000
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.058 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.015 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.084 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.0 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.366 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.012 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.003 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.0 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.020 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.044 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.35 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.383 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.001 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.209 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.021 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.024 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.011 pure
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
5600000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1200000
CY2014Q4 amed Deferred Tax Assets Deferred Expense Us Department Of Justice Settlement Accrual
DeferredTaxAssetsDeferredExpenseUsDepartmentOfJusticeSettlementAccrual
0
CY2014Q4 amed Deferred Tax Assets Other Current
DeferredTaxAssetsOtherCurrent
1800000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1100000
CY2013Q4 amed Deferred Tax Assets Other Current
DeferredTaxAssetsOtherCurrent
1400000
CY2013Q4 amed Deferred Tax Assets Deferred Expense Us Department Of Justice Settlement Accrual
DeferredTaxAssetsDeferredExpenseUsDepartmentOfJusticeSettlementAccrual
59300000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
5600000
CY2014Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
31300000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
122400000
CY2013Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
24100000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
145500000
CY2014Q4 amed Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Workers Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsWorkersCompensation
8100000
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
-102600000
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
-89200000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3300000
CY2013Q4 us-gaap Deferred Tax Assets Other Loss Carryforwards
DeferredTaxAssetsOtherLossCarryforwards
5300000
CY2014Q4 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
16800000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
200000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2600000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
188300000
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
170500000
CY2013Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
42600000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
0
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
0
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
3500000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4000000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
0.85 pure
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3900000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
400000
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
100000
CY2014 amed Number Of Individual States Subject To Income Tax
NumberOfIndividualStatesSubjectToIncomeTax
50 States
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
300000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2013 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
-200000
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
0
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
100000
CY2014 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
100000
CY2013 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
100000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4000000
CY2014 amed Percentageofownershipinsubsidiaries
Percentageofownershipinsubsidiaries
0.5 pure
CY2014 amed Percentageoftotalcombinedvotingpowerofthecompanyandoursubsidiaries
Percentageoftotalcombinedvotingpowerofthecompanyandoursubsidiaries
0.1 pure
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1300000 shares
CY2014Q4 amed Common Stock Shares Authorized For Issuance To Employee Stock Purchase Plan
CommonStockSharesAuthorizedForIssuanceToEmployeeStockPurchasePlan
1600472 shares
CY2013 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
500000
CY2012 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
700000
CY2014 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
2899528 shares
CY2014 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
400000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
250000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
800000
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
200000
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3300000
CY2014 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
20400000
CY2013 amed Market Based Award Target Share Amount
MarketBasedAwardTargetShareAmount
417330 shares
CY2013 amed Market Based Award Maximum Share Amount
MarketBasedAwardMaximumShareAmount
667728 shares
CY2014 amed Corporate Integrity Agreement Term
CorporateIntegrityAgreementTerm
P5Y
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
14200000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
9000000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
4700000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1800000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
300000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
50400000
CY2014Q4 amed Operating Lease Commitments For Discontinued Operations
OperatingLeaseCommitmentsForDiscontinuedOperations
300000
CY2014 amed Operating Leases Rent Expense Net For Continuing Operations
OperatingLeasesRentExpenseNetForContinuingOperations
26500000
CY2013 amed Operating Leases Rent Expense Net For Continuing Operations
OperatingLeasesRentExpenseNetForContinuingOperations
29800000
CY2012 amed Operating Leases Rent Expense Net For Continuing Operations
OperatingLeasesRentExpenseNetForContinuingOperations
30700000
CY2014 amed Health Insurance
HealthInsurance
11200000
CY2014 amed Wokers Compensation
WokersCompensation
20800000
CY2014 amed Professional Liability
ProfessionalLiability
3900000
CY2014 amed Estimated Insurance Long Term Portion
EstimatedInsuranceLongTermPortion
-1000000
CY2014 amed Estimated Insurance Excluding Long Term Portion
EstimatedInsuranceExcludingLongTermPortion
34900000
CY2013 amed Health Insurance
HealthInsurance
12200000
CY2013 amed Wokers Compensation
WokersCompensation
17700000
CY2013 amed Professional Liability
ProfessionalLiability
4700000
CY2013 amed Estimated Insurance Total
EstimatedInsuranceTotal
34600000
CY2013 amed Estimated Insurance Long Term Portion
EstimatedInsuranceLongTermPortion
-1200000
CY2013 amed Estimated Insurance Excluding Long Term Portion
EstimatedInsuranceExcludingLongTermPortion
33400000
CY2014 amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
900000
CY2014 amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000
CY2014 amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000
CY2014 amed Minimum Eligible Age For Employees To Contribute To Benefit Plan
MinimumEligibleAgeForEmployeesToContributeToBenefitPlan
21
CY2014 amed Deferred Compensation Arrangement Maximum Percentage Of Salary Deferment
DeferredCompensationArrangementMaximumPercentageOfSalaryDeferment
0.75 pure
CY2014 amed Deferred Compensation Arrangement Maximum Percentage Of Annual Bonus Deferment
DeferredCompensationArrangementMaximumPercentageOfAnnualBonusDeferment
1 pure
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6200000
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
7800000
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
9700000
CY2014 amed Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
0.375
CY2014 amed Defined Contribution Plan Employee Contribution For Employee Matching Program
DefinedContributionPlanEmployeeContributionForEmployeeMatchingProgram
1.00
CY2014 amed Defind Contribution Plan Maximum Annual Match Per Employee Salary Percentage
DefindContributionPlanMaximumAnnualMatchPerEmployeeSalaryPercentage
0.06 pure
CY2013 amed Defind Contribution Plan Maximum Annual Match Per Employee Salary Percentage
DefindContributionPlanMaximumAnnualMatchPerEmployeeSalaryPercentage
0.06 pure
CY2013 amed Defined Contribution Plan Employee Contribution For Employee Matching Program
DefinedContributionPlanEmployeeContributionForEmployeeMatchingProgram
1.00
CY2013 amed Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
0.375
CY2012 amed Defined Contribution Plan Employer Matching Contribution
DefinedContributionPlanEmployerMatchingContribution
0.375
CY2012 amed Defined Contribution Plan Employee Contribution For Employee Matching Program
DefinedContributionPlanEmployeeContributionForEmployeeMatchingProgram
1.00
CY2012 amed Defind Contribution Plan Maximum Annual Match Per Employee Salary Percentage
DefindContributionPlanMaximumAnnualMatchPerEmployeeSalaryPercentage
0.06 pure
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-91100000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
1800000
CY2013Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
315900000
CY2014 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
441700000
CY2013 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
474000000
CY2012 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
516700000
CY2014 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segments
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
7600000
CY2014Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
305000000
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
8400000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2014Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
300300000
CY2013Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
301300000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.89
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.89
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2013Q4 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
303500000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-9600000
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2014Q4 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
300500000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
9100000
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2013Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
328600000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
2700000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2014Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
298700000

Files In Submission

Name View Source Status
0001193125-15-076564-index-headers.html Edgar Link pending
0001193125-15-076564-index.html Edgar Link pending
0001193125-15-076564.txt Edgar Link pending
0001193125-15-076564-xbrl.zip Edgar Link pending
amed-20141231.xml Edgar Link completed
amed-20141231.xsd Edgar Link pending
amed-20141231_cal.xml Edgar Link unprocessable
amed-20141231_def.xml Edgar Link unprocessable
amed-20141231_lab.xml Edgar Link unprocessable
amed-20141231_pre.xml Edgar Link unprocessable
d861886d10k.htm Edgar Link pending
d861886dex1012.htm Edgar Link pending
d861886dex106.htm Edgar Link pending
d861886dex107.htm Edgar Link pending
d861886dex108.htm Edgar Link pending
d861886dex109.htm Edgar Link pending
d861886dex211.htm Edgar Link pending
d861886dex231.htm Edgar Link pending
d861886dex311.htm Edgar Link pending
d861886dex312.htm Edgar Link pending
d861886dex321.htm Edgar Link pending
d861886dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g861886g02k04.jpg Edgar Link pending
g861886g57p17.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending